Withus Pharmaceutical Co Ltd (330350) Stock Price & News

330350:KOSDAQ

Withus Pharmaceutical Co Ltd

₩6,780.00

+0.74%

(+50.00) 1D

Nov 11, 3:30:18 PM GMT+9 · KRW

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 330350...

Open

₩6,730

High

₩6,900

Low

₩6,580

Mkt. cap

89.49B

Avg. vol.

141.02K

Volume

100.48K

P/E ratio

11.24

52-wk high

₩11,950

52-wk low

₩5,910

EPS

₩603

Shares outstanding

13.20M

No. of employees

218

Open

₩6,730

High

₩6,900

Low

₩6,580

Mkt. cap

89.49B

Avg. vol.

141.02K

Volume

100.48K

P/E ratio

11.24

52-wk high

₩11,950

52-wk low

₩5,910

EPS

₩603

Shares outstanding

13.20M

No. of employees

218

Related stocks

Dongsung Pharmaceutical Co Ltd

Hyundai Pharmaceutical Co Ltd

₩6,690.00

+1.06%

News stories

From web sources and news partners

XTB.com

19 minutes ago

📈 US500 continues its rebound

Serbian News Media

1 hour ago

Inflation above expectations and stock decline on Wall Street

Yahoo Finance

8 hours ago

Amazon’s Cloud Computing Business Already Brings in More Revenue Than 476 Companies in the S&P 500. Here’s What It Would Take to Reach $1 Trillion.

FXStreet

1 hour ago

Dow Jones futures surge as easing geopolitical risks, AI earnings revive market sentiment

About Withus Pharmaceutical Co Ltd

CEO-

Employees218

Founded2004

Headquarters-

SectorHealth Care

IndustryPharmaceutical industry

Websitewithuspharm.com

All values in KRW	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	27.25B	27.18B	28.22B	29.07B
Cost of goods sold	9.53B	9.88B	10.00B	10.42B
Cost of revenue	9.53B	9.88B	10.00B	10.42B
Research and development expenses	-	452.18M	565.05M	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	16.35B	15.00B	16.79B	17.57B
Operating expense	16.35B	15.92B	17.98B	17.57B
Total operating expenses	25.88B	25.80B	27.97B	28.00B
Operating income	1.37B	1.38B	244.17M	1.08B
Other non operating income	1.26B	-108.94M	113.80M	1.40B
EBT including unusual items	2.63B	-1.57B	711.51M	2.47B
EBT excluding unusual items	2.63B	1.26B	370.21M	2.47B
Income tax expense	483.36M	-1.45B	-3.26B	505.02M
Effective tax rate	18.39%	92.33%	-458.19%	20.42%
Other operating expenses	-	40.81M	53.43M	-
Net income	2.14B	-120.28M	3.97B	1.97B
Net profit margin	7.87%	-0.44%	14.08%	6.77%
Earnings per share	-	-	-	-
Interest and investment income	-	151.87M	155.00M	-
Interest expense	-	-165.04M	-138.27M	-
Net interest expenses	-	-13.17M	16.73M	-
Depreciation and amortization charges	-	92.72M	149.77M	-
EBITDA	2.41B	2.43B	1.32B	2.16B
Gain or loss from assets sale	-	-	-	-

Ask anything